Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

Overview | Financials
Company Name Arrowhead Pharmaceuticals, Inc.
Symbol ARWR
Currency USD
Price 22.22
Market Cap 2,762,279,300
Dividend Yield 0%
52-week-range 20.67 - 39.83
Industry Biotechnology
Sector Healthcare
CEO Dr. Christopher R. Anzalone Ph.D.
Website https://arrowheadpharma.com

An error occurred while fetching data.

About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in

Related Stocks

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

30.18 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

11.63 USD

LivaNova PLC logo

LivaNova PLC

LIVN

47.06 USD

Natera, Inc. logo

Natera, Inc.

NTRA

112.9 USD

Guardant Health, Inc. logo

Guardant Health, Inc.

GH

23.73 USD

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

96.58 USD

Amedisys, Inc. logo

Amedisys, Inc.

AMED

97.17 USD

CureVac N.V. logo

CureVac N.V.

CVAC

2.74 USD

Cerevel Therapeutics Holdings, Inc. logo

Cerevel Therapeutics Holdings, Inc.

CERE

44.96 USD

Financials

Numbers are in millions USD

Numbers are in millions USD